FEMY
Femasys Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$2.98
−2.61%Aug 26, 2026, 13:00 UTC
Femasys Inc. announced a partnership with UNC Health to introduce its fertility products FemVue, SpermVue, and FemaSeed Complete across UNC Health OB/GYN practice locations.
Source:Aug 19, 2026, 17:36 UTC
The U.S. Food and Drug Administration (FDA) authorized the modular premarket approval application pathway for Femasys's FemBloc non-surgical permanent birth control technology on Wednesday.
Source:Aug 14, 2026, 20:05 UTC
Femasys Inc. announced its financial results for the quarter ended June 30, 2026.
Source:Aug 7, 2026, 13:25 UTC
Femasys Inc. announced a $30 million private placement of securities with accredited investors, led by Nantahala Capital, with potential additional proceeds of up to $90 million from warrant exercises, expected to close around August 10, 2026.
Jun 24, 2026, 13:00 UTC
Femasys Inc. received formal notice from Nasdaq confirming it has regained compliance with the minimum bid price listing requirement.
Source: